Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

por Schuind, Anne, Segall, Nathan, Drame, Mamadou, Innis, Bruce L.
Publicado 2015

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults

por Dagnew, Alemnew F, Vink, Peter, Drame, Mamadou, Willer, David, Salaun, Bruno, Schuind, Anne
Publicado 2020

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis...

por Dagnew, Alemnew F, Rausch, Debora, Hervé, Caroline, Zahaf, Toufik, Levin, Myron J, Schuind, Anne
Publicado 2020

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

por Dagnew, Alemnew F., Vink, Peter, Drame, Mamadou, Willer, David O., Salaun, Bruno, Schuind, Anne E.
Publicado 2021

2319. Clinical Predictors of Influenza and Hospitalization of Children with Influenza in an Emergent Care Setting

por Rao, Suchitra, Lamb, Molly, Moss, Angela, Yanni, Emad, Bekkat-Berkani, Rafik, Schuind, Anne, Innis, Bruce, Asturias, Edwin J
Publicado 2019

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

por Dagnew, Alemnew F, Klein, Nicola P, Hervé, Caroline, Kalema, George, Di Paolo, Emmanuel, Peterson, James, Salaun, Bruno, Schuind, Anne
Publicado 2020

Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card

por de Lusignan, Simon, Ferreira, Filipa, Damaso, Silvia, Byford, Rachel, Pathirannehelage, Sameera, Yeakey, Anne, Yonova, Ivelina, Schuind, Anne, Dos Santos, Gael
Publicado 2019

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system

por Friel, Damien, Co, Mary, Ollinger, Thierry, Salaun, Bruno, Schuind, Anne, Li, Ping, Walravens, Karl, Ennis, Francis A., Vaughn, David W.
Publicado 2020

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

por Madan, Anuradha, Segall, Nathan, Ferguson, Murdo, Frenette, Louise, Kroll, Robin, Friel, Damien, Soni, Jyoti, Li, Ping, Innis, Bruce L., Schuind, Anne
Publicado 2016

Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis

por de Lusignan, Simon, Dos Santos, Gaël, Byford, Rachel, Schuind, Anne, Damaso, Silvia, Shende, Vishvesh, McGee, Chris, Yonova, Ivelina, Ferreira, Filipa
Publicado 2018

7. Can Recombinant Zoster Vaccine Administration Decrease the Use of Herpes Zoster-related Pain Medication Across Randomized Controlled Studies?

por Kim, Joon Hyung, Johnson, Robert, Kovac, Martina, Cunningham, Anthony L, Emmadi, Srikanth, Sullivan, Keith, Dagnew, Alemnew F, Curran, Desmond, Schuind, Anne
Publicado 2020

8. The Adjuvanted Recombinant Zoster Vaccine (RZV) Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study (ZOSTER-049) of Two Clinical Trials (ZO...

por Boutry, Céline, Hastie, Andrew, Shi, Meng, Diez-Domingo, Javier, Tinoco, Juan Carlos, Yu, Chong-Jen, Pirrotta, Paola, Kalema, George, Schuind, Anne
Publicado 2020

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials

por Kim, Joon Hyung, Johnson, Robert, Kovac, Martina, Cunningham, Anthony L., Amakrane, Mohamed, Sullivan, Keith M., Dagnew, Alemnew F., Curran, Desmond, Schuind, Anne
Publicado 2023

986. Evaluation of Moderate-to-Severe Influenza Disease in Children 6 Months to 8 Years of Age in Colorado

por Rao, Suchitra, Lamb, Molly, Moss, Angela, Yanni, Emad, Bekkat-Berkani, Rafik, Schuind, Anne, Innis, Bruce, Cotter, Jillian, Mistry, Rakesh, Asturias, Edwin J
Publicado 2018

Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study

por Kiendrébéogo, Joël Arthur, Sidibe, Annick Raissa O., Compaoré, Ghislain Bertrand, Nacanabo, Relwendé, Sory, Orokia, Ouédraogo, Issa, Nawaz, Saira, Schuind, Anne E, Clark, Andrew
Publicado 2023

37. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine (RZV) in Immunocompromised Populations: an Overview of 6 Trials

por Fauqued, Marta Lopez, Co, Maribel Miranda, Bastidas, Adriana, Beukelaers, Pierre, Dagnew, Alemnew F, Garcia, Juan Jose Fernandez, Schuind, Anne, da Silva, Fernanda Tavares
Publicado 2020

2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine

por Schmader, Kenneth E, Levin, Myron J, Chen, Michael, Matthews, Sean, Riley, Megan, Woo, Wayne, Hervé, Caroline, Grupping, Katrijn, Schuind, Anne, Oostvogels, Lidia, Curran, Desmond
Publicado 2019

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-...

por Mrkvan, Tomas, Campora, Laura, Catteau, Grégory, Douha, Martine, Grupping, Katrijn, Herve, Caroline, Kalema, George, Heineman, Thomas, Klein, Nicola P, Lal, Himal, Oostvogels, Lidia, Schuind, Anne
Publicado 2018

2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1

por Colindres, Romulo, Wascotte, Valentine, Brecx, Alain, Clarke, Christopher, Hervé, Caroline, Hyung Kim, Joon, Levin, Myron J, Oostvogels, Lidia, Zahaf, Toufik, Schuind, Anne, Cunningham, Anthony L
Publicado 2019

Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children

por Hsiao, Amber, Buck, Philip O., Yee, Arnold, Hansen, John, Lewis, Edwin M., Aukes, Laurie L., Yanni, Emad, Bekkat-Berkani, Rafik, Schuind, Anne, Klein, Nicola P.
Publicado 2020